Retisert (Fluocinolone Acetonide Intravitreal Implant) Patient Information: Missed a Dose and What Should I Avoid at RxList

Pill Identifier Search

May 27, 2012

Retisert

Uveitis »

Introduction

Uveitis (pronounced you-vee-EYE-tis) is basically an inflammation of the eye. The condition involves all inflammatory processes of the middle layers of the eye, also called the uveal tract or uvea. The uvea includes the iris (colored part of the eye), choroid (a thin membrane containing many blood vessels) and ciliary body (the part of the eye that joins these together).

The uvea is very important because its many veins and arteries transport blood to the parts of the eye that are critical for vision.

Learn more about the structures that make up the eye in the article titled " The Amazing Human Eye ."

What Are the Symptoms of Uveitis?

Symptoms of uveitis may include:

Eye redness and irritation
Blurred vision
Eye pain
Increased sensitivity to light ...

Read the Uveitis article »

« Previous
1
2
3
4
5
6
7
8
9
10
Next »

Retisert

Eye Diseases and Conditions Slideshow Pictures

Pink Eye Slideshow Pictures

Cataracts Slideshow Pictures

font size

Retisert Patient Information including If I Miss a Dose

What happens if I miss a dose (Retisert)?

Since the fluocinolone ophthalmic implant is surgically put into place, you will not be on a dosing schedule for this medication.

If you are taking medication to control pressure inside your eyes and you miss a dose, take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose and take the medicine at your next regularly scheduled time. Do not take extra medicine to make up the missed dose.

What happens if I overdose (Retisert)?

An overdose of fluocinolone is unlikely to occur with the ophthalmic implant.

What should I avoid after receiving a fluocinolone ophthalmic implant (Retisert)?

Do not use any eye medications that your doctor has not prescribed.

Fluocinolone ophthalmic implant can cause dizziness or blurred vision. Be careful if you drive or do anything that requires you to be alert and able to see clearly.

Avoid wearing contact lenses after receiving the fluocinolone ophthalmic implant unless your doctor has told you to.

What other drugs will affect fluocinolone ophthalmic implant (Retisert)?

Before using this medication, tell your doctor if you are using any other steroid medications, including:

nasal or inhaled steroids such as budesonide (Pulmicort, Rhinocort, Symbicort), flunisolide (AeroBid, Nasarel), fluticasone (Advair, Flonase, Flovent), mometasone (Asmanex, Nasonex), or triamcinolone (Azmacort); or
steroid medication taken by mouth such as betamethasone (Celestone), budesonide (Entocort), dexamethasone (Decadron, Hexadrol), fludrocortisone (Florinef), hydrocortisone (Cortef, Hydrocortone), prednisone (Deltasone, Meticorten, Orasone, others), methylprednisolone (Medrol), triamcinolone (Aristocort).

There may be other drugs that can affect fluocinolone ophthalmic implant. Tell your doctor about all the prescription and over-the-counter medications you use. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start using a new medication without telling your doctor.

Where can I get more information?

Your doctor can provide more information about fluocinolone ophthalmic implant written for health professionals that you may read.

Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 1996-2010 Cerner Multum, Inc. Version: 3.02. Revision date: 4/12/2009.

Your use of the content provided in this service indicates that you have read,understood and agree to the End-User License Agreement,which can be accessed by clicking on this link.